Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity (Tables)

v3.25.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders Equity [Abstract]  
Schedule of Outstanding and Exercisable Warrants

The following table reflects all outstanding and exercisable warrants at December 31, 2024 and 2023:

 

    Number of Warrants Outstanding     Weighted Average Exercise Price     Weighted Average Life (Years)     Aggregate Intrinsic Value  
Balance January 1, 2023     10,074,195     $ 4.91       5.0     $
 
Balance December 31, 2023     10,074,195     $ 4.91       4.0     $
 
Balance December 31, 2024     10,074,195     $ 4.91       3.0     $
 
Schedule of Purchases made by the Company

Below is a table containing information about purchases made by the company during the year ended December 31, 2023. The Company did not repurchase any shares during the year ended December 31, 2024.

 

Period  

Total Number

of Shares

Purchased

   

Average Price

Paid per Share

   

Total Number of Shares Purchased as Part of Publicly

Announced Plans or Programs

    Maximum Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs  
January 1, 2023 - December 31, 2023     37,509     $ 1.32       1,815,166     $ 6,618